370 related articles for article (PubMed ID: 7493603)
1. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
Starr MS; Starr BS
Eur J Pharmacol; 1995 Apr; 277(2-3):151-8. PubMed ID: 7493603
[TBL] [Abstract][Full Text] [Related]
2. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
Koshikawa N; Kitamura M; Kobayashi M; Cools AR
Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
[TBL] [Abstract][Full Text] [Related]
3. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
Starr BS; Starr MS; Kilpatrick IC
Neuroscience; 1987 Jul; 22(1):179-88. PubMed ID: 2957609
[TBL] [Abstract][Full Text] [Related]
4. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
Koshikawa N; Miwa Y; Adachi K; Kobayashi M; Cools AR
Eur J Pharmacol; 1996 Jul; 308(3):227-34. PubMed ID: 8858292
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine and quinpirole, but not 7-OH-DPAT or SKF 38393, potentiate the inhibitory effect of L-NAME on ethanol-induced locomotor activity in mice.
Uzbay IT; Kayir H
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):414-21. PubMed ID: 12690434
[TBL] [Abstract][Full Text] [Related]
6. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
Dall'Olio R; Gaggi R; Voltattorni M; Tanda O; Gandolfi O
Behav Pharmacol; 2002 Dec; 13(8):633-8. PubMed ID: 12478213
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic modulation of rat pup ultrasonic vocalizations.
Dastur FN; McGregor IS; Brown RE
Eur J Pharmacol; 1999 Oct; 382(2):53-67. PubMed ID: 10528139
[TBL] [Abstract][Full Text] [Related]
8. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
Protais P; Lesourd M; Comoy E
Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
[TBL] [Abstract][Full Text] [Related]
9. Effects of putative dopamine D3 receptor agonists, 7-OH-DPAT, and quinpirole, on yawning, stereotypy, and body temperature in rats.
Kurashima M; Yamada K; Nagashima M; Shirakawa K; Furukawa T
Pharmacol Biochem Behav; 1995 Nov; 52(3):503-8. PubMed ID: 8545466
[TBL] [Abstract][Full Text] [Related]
10. D2 and D1 dopaminergic activity of 7-OH-DPAT.
Sethy VH; Ellerbrock BR; Fici GJ; Wu H
Brain Res; 1996 Sep; 733(1):41-5. PubMed ID: 8891246
[TBL] [Abstract][Full Text] [Related]
11. Biphasic effects of D3-receptor agonists, 7-OH-DPAT and PD128907, on the D1-receptor agonist-induced hyperactivity in mice.
Mori T; Murase K; Tanaka J; Ichimaru Y
Jpn J Pharmacol; 1997 Mar; 73(3):251-4. PubMed ID: 9127821
[TBL] [Abstract][Full Text] [Related]
12. Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice.
Starr BS; Starr MS
Neuropharmacology; 1987 Jun; 26(6):613-9. PubMed ID: 2955244
[TBL] [Abstract][Full Text] [Related]
13. Facilitation of dopamine D1 receptor- but not dopamine D1/D2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse.
Starr MS; Starr BS
Eur J Pharmacol; 1993 Dec; 250(2):239-46. PubMed ID: 7906652
[TBL] [Abstract][Full Text] [Related]
14. Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat.
Silvestre JS; O'Neill MF; Fernandez AG; Palacios JM
Eur J Pharmacol; 1996 Dec; 318(2-3):257-65. PubMed ID: 9016913
[TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
Protais P; Chagraoui A; Arbaoui J; Mocaër E
Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
[TBL] [Abstract][Full Text] [Related]
16. Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward.
Ikemoto S; Glazier BS; Murphy JM; McBride WJ
J Neurosci; 1997 Nov; 17(21):8580-7. PubMed ID: 9334429
[TBL] [Abstract][Full Text] [Related]
17. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
[TBL] [Abstract][Full Text] [Related]
18. Selective attenuation of the antinociceptive effects of mu opioids by the putative dopamine D3 agonist 7-OH-DPAT.
Cook CD; Rodefer JS; Picker MJ
Psychopharmacology (Berl); 1999 Jun; 144(3):239-47. PubMed ID: 10435390
[TBL] [Abstract][Full Text] [Related]
19. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice.
Starr MS; Starr BS
Psychopharmacology (Berl); 1994 Apr; 114(3):469-76. PubMed ID: 7855205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
